baber/WOPTO huggingface dataset:
Patent AT-E404214-T1 (AT)
Inventor: WOODROW WAYNE
IPC: A61K47/02
Filed: 2001-02-02
Granted: 2008-08-15
Abstract: Pharmaceutical compositions containing a small or medium size peptide, free from preservatives and stable before and during the use.
Patent AT-E315309-T1 (AT)
Inventor: REITH LOTHAR
IPC: H04L12/14
Filed: 2001-03-22
Granted: 2006-02-15
Abstract: Method of providing telecommunications services, wherein users are authenticated and authorized to a first service profile before a user session starts, characterized in that the service profile is dynamically varied in the course of the session. <IMAGE>
Patent AT-E340884-T1 (AT)
Inventor: JOERISSEN JAKOB DR-ING
IPC: C25B1/46
Filed: 2001-06-15
Granted: 2006-10-15
Abstract: Chlor-alkali electrolysis comprises using an electrolysis cell having an anode chamber with an anode separated from a cathode chamber with a cathode by a membrane. Water is fed to the side of the cathode chamber and a saturated sodium chloride (NaCl) solution is fed to the side of the anode chamber. A mixture of aqueous sodium hydroxide and hydrogen gas is produced by electrolysis on the cathode side, and chlorine gas is produced on the anode side forming a lean sol. The membrane is in the acid state. The mixture of aqueous sodium hydroxide and hydrogen gas is removed on the cathode outlet of the electrolysis cell and the chlorine gas and oxygen are removed on the anode side of the cell. An Independent claim is also included for an apparatus for carrying out the process. Preferred Features: The chlorine gas removed on the anode side is free from lean sol. The aqueous sodium hydroxide has a concentration of less than 20, preferably 2-5 wt.% NaOH. The membrane is a cation exchange membrane, preferably made of a polymer derivative with sulfonyl groups. The polymer is a polymer based on perfluorinated hydrocarbons. The aqueous sodium hydroxide and the chlorine are used in the production of a chlorine bleaching solution. The anode is coated with mixed oxides based on iridium oxide and tantalum oxide.
Patent AT-E274931-T1 (AT)
Inventor: BALSCHAT KLAUS
IPC: A61M1/14
Filed: 2001-06-18
Granted: 2004-09-15
Abstract: A machine and method for preparing dialysis fluid for a dialysis machine. Fresh water is mixed with one or more dialysis fluid concentrates. The mixture of water and concentrates is conveyed into an equalizing chamber by a proportioning unit at a predetermined flow rate independent of the dialysate flow rate. Metered addition of the concentrates is performed volumetrically and is monitored on the basis of the conductivity of the dialysis fluid, which is measured by conductivity sensors. Because the mixture of water and concentrates is always conveyed at the same flow rate, the composition of the dialysis fluid can be determined with a high accuracy and the proportioning can be performed accurately.
Patent AT-E431260-T1 (AT)
Inventor: TOMPKIN WAYNE ROBERT
IPC: B42D15/10
Filed: 1996-11-14
Granted: 2009-05-15
Abstract: An optical information carrier is in the form of a composite laminate having diffractive first relief structures (10) embossed into the underside (4) of the carrier foil (3) to produce visual optical-diffractive effects and optionally diffractive second relief structures (10) embossed into the top side (5) of the carrier foil (3). The top side (5) are provided with an optically effective relief structure (7) formed by layers of a dielectric (9) which form a machine readable information by covering or exposing the relief structure (15) of the underside (4) along a data track. A lacquer layer (29) covers the dielectric layers (9) and the neighbouring parts of the top side (5). The dielectric layers (9) differ in refractive index from the refractive indices of the adjoining materials of the carrier foil (3) and the lacquer layer (29). The materials of the carrier foil (3) and the lacquer layer (29) may have the same refractive index and allow light impinging on the top side (5) to penetrate at least partially into the composite laminate. <IMAGE>
Patent AT-E353983-T1 (AT)
Inventor: SPANJERS MARTINUS GODEFRIDUS J
IPC: C22C21/06
Filed: 2001-03-15
Granted: 2007-03-15
Abstract: The invention relates to an aluminium-magnesium alloy for casting operations consisting of, in weight percent, Mg 2.7-6.0, Mn 0.4-1.4, Zn 0.10-1.5, Zr 0.3 max., V 0.3 max., Sc 0.3 max., Ti 0.2 max., Fe 1.0 max., Si 1.4 max., balance aluminium and inevitable impurities. The casting alloy is particularly suitable for application in die-casting operations. Further the invention relates to the use of the casting alloy for die-casting automotive components.
Patent AT-E387128-T1 (AT)
Inventor: SHARPE RICHARD
IPC: A47J37/10
Filed: 2001-04-18
Granted: 2008-03-15
Abstract: A digital frying pan (10), provides temperature and/or food doneness information associated with food cooked within the pan. A thermal sensor (11) coupled with the pan senses temperature and generates corresponding signals, and processing electronics coupled with the sensor convert the signals to data for display on a LCD. A warning buzzer (82) or LED warns the user of completed cooking. The frying pan may be programmed to desired food types or personal temperatures or food doneness options. The invention also provides a remote sensing food doneness system for remotely viewing and then determining food temperature and/or food doneness. The remote system uses thermal imaging optics and thermal sensing techniques to remotely sense food temperature. Preferably a second optical element images the food onto a CCD to display an image of the food to a user. The system is mounted by a user who views the CCD to ensure appropriate placement in line of sight from the food. A warning is generated by the system to indicate food doneness or desired temperature.
Patent AT-E379905-T1 (AT)
Inventor: BARKAI SHARON
IPC: H04L12/24
Filed: 2001-04-27
Granted: 2007-12-15
Abstract: A method for topology discovery in an ATM network, the method including identifying an active VC between two ATM network device ports, and maintaining a link between the ATM network device ports in a topology graph where the active VC has the same VPI/VCI at both of the ports.
Patent AT-E412185-T1 (AT)
Inventor: HAGEMAN GREGORY
IPC: G01N33/493
Filed: 2001-04-30
Granted: 2008-11-15
Abstract: The invention relates to methods for treating, preventing and diagnosing macular degeneration-related disorders.
Patent AT-E268065-T1 (AT)
Inventor: DOORHY MICHAEL V
IPC: H01R24/00
Filed: 2001-01-12
Granted: 2004-06-15
Abstract: A modular communications connector including a housing defining a plug receiving opening, a conductor carrying sled including a printed circuit board designed in conjunction with a specific conductor design having two sets of contacts, one running under the printed circuit board and the other running over the top of the printed circuit board s to improve crosswalk performance. The connector further includes a wire containment fixture arrangement allowing for simplified field termination of the modular connector. The connector is assembled by loading the contacts and printed circuit board onto the sled which is snap fit into the housing, positioning wires through the wire containment fixture and slidably engaging the fixture to the sled to terminate the wires.
Patent AT-E281839-T1 (AT)
Inventor: SMITH ELDON R
IPC: A61K45/00
Filed: 2001-01-18
Granted: 2004-11-15
Abstract: A method of treating congestive heart failure (CHF) in a human patient comprises treating an aliquot of the patients blood ex vivo with at least one stressor selected from the group consisting of a temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering the aliquot of treated blood to the patient. The treatment can be used on its own or as an adjunctive therapy in combination with conventional CHF treatments.
Patent AT-E474064-T1 (AT)
Inventor: GUT IVO
IPC: C12Q1/68
Filed: 2001-06-29
Granted: 2010-07-15
Abstract: The invention is drawn to a universal method for preparing DNA samples for genotyping of single nucleotide polymorphisms (SNP), deletions and insertions by mass spectrometry. The invention relates to a method for genotyping that comprises three steps:     a. reducing the complexity of the genome,   b. generating allele specific products, c. analyzing the products by mass spectrometry.
Patent AT-E261012-T1 (AT)
Inventor: BALTES HANS
IPC: D06F58/10
Filed: 2001-06-18
Granted: 2004-03-15
Abstract: The invention describes a method for the drying of a damp material (2), whereby the material (2) is treated in a treatment chamber (15) of a drying cabinet (1) in a mechanically immobile condition, in which air (10) is directed through the treatment chamber (15) and over a condenser (13) and the moisture in the air (10) can condense at the condenser (13) and be led away. The air (10) is led about the material (2) for drying at least during a period of the drying of the material (2) in a closed loop through the treatment chamber (15) in which the material (2) at increasing temperature in the treatment chamber (15) is exposed to steam or increased humidity generated at least partly from the dampness of the material (2) or the increased humidity of the air (10) circulating around and is relaxed and smoothed by the steam or the increased humidity in relation to creases, folds or similar from preceding treatments, and with an increasing dehumidify of the residual humidity of the air (10) after the beginning of the condensation at the condenser (13) the material (2) then is freed from creases, folds or similar and therefore is then dried largely without ironing. Further the invention describes a drying cabinet (1) for the drying of the damp material (2) is treated in a treatment chamber (15) of a drying cabinet (1) in mechanically immobile condition which shows flaps (21, 22) to be switched between the circulation in the closed circulation and a treatment in the open circulation which make possible an introduction and exhausting from external air.
Patent AT-E354669-T1 (AT)
Inventor: SOUMILLION PATRICE
IPC: A61K47/48
Filed: 2001-06-07
Granted: 2007-03-15
Abstract: The invention is in particular related to a method for the selective survival or selective growth of a target cell comprising the steps of: a) contacting the target cell with a conjugate compound A-B, wherein A is a selective antibody or antibody derivative recognizing the target cell and B is a biotic agent able to at least partially inactivate an anti-bios agent, said anti-bios agent is able to inhibit the growth of cells; and b) contacting the target cell with the anti-bios agent. The present invention also relates to said conjugate on its own, a selection medium for cells comprising said conjugate and cells that are selected or recognized using a method or conjugate according to the present invention. The present invention further elucidates a pharmaceutical compound or composition, a kit for the detection of a target cell or for the diagnosis of diseases caused by the target cell or a product that can be used in the therapy of infectious related diseases comprising a conjugate according to present invention.
Patent AT-E511846-T1 (AT)
Inventor: CASU B
IPC: A61K47/36
Filed: 2001-09-12
Granted: 2011-06-15
Abstract: Totally N-desulphated, N-reacetylated heparin derivatives endowed with antiangiogenic activity and devoid of anticoagulant activity are disclosed.
Patent AT-E412776-T1 (AT)
Inventor: MAEKAWA TAKAMI
IPC: C12N15/10
Filed: 2001-11-06
Granted: 2008-11-15
Abstract: Each gene in a group comprising many genes is cloned into an expression vector so that its gene product should be expressed as a fusion protein with a protein emitting self-fluorescence to construct a gene expression library. The gene expression library is introduced into cells of two groups to express the fusion proteins in the cells, and only one cell group is stimulated by a drug or the like. Then, cells in which the fusion proteins are localized in the nuclei or their nuclei are isolated from cells of the two groups, respectively. By comparing these cells, genes coding for proteins that are transported into the nuclei specifically in response to a certain stimulus when the stimulus is applied to the cells are retrieved. <IMAGE>
Patent AT-E447959-T1 (AT)
Inventor: DONG QINGBIN
IPC: C07D491/16
Filed: 2001-09-11
Granted: 2009-11-15
Abstract: The present invention relates to the use of sodium channel blocking compounds such as tetrodotoxin, saxitoxin as well as anolgs and derivatives thereof for the preparation of a pharmaceutical composition for systemic administration for producing analgesia in a mammal experiencing pain.
Patent AT-E295165-T1 (AT)
Inventor: WESSEL KLAUS
IPC: C07D339/04
Filed: 2001-06-07
Granted: 2005-05-15
Abstract: The use of alpha -lipoic acid compounds (I) is claimed for the adjuvant therapy of dementia, where (I) is selected from alpha -lipoic acid in reduced or oxidized form or its derivatives having an intact dithiolan structure in the form of enantiomers or salts, amides, esters, thioesters, ethers or metabolites. An independent claim is included for a composition containing (I) in combination with at least one anti-dementia agent (II) or at least one neurotransmission improving agent (III). - ACTIVITY : Nootropic; neuroprotective; antiparkinsonian; anti-HIV. - MECHANISM OF ACTION : Antioxidant.
Patent AT-E347024-T1 (AT)
Inventor: STORM MARK
IPC: F01N1/04
Filed: 2001-12-20
Granted: 2006-12-15
Abstract: The use of fiber metal or similarly high flow resistance and high acoustic transparency material as a liner for traditional acoustically absorptive media in a dissipative muffler exhibits improved low frequency sound attenuation, reduces backpressure, and eliminates media entrainment or "blow-out" phenomenon which results in longer muffler life. The same class of materials may also be used to fashion an element that provides linear occlusion inside an otherwise line-of-sight type of muffler, where the occluding element provides improved impedance-matching acoustic absorption. Disclosed embodiments providing linear occlusion minimize traditional increases in muffler backpressure by incorporating helical, conical, and annular members in mufflers with round ducts. To maximize attenuation, a muffler according to the invention may feature both a fiber metal fill liner and a fiber metal linear occlusion element. Further, the liner that connects the inlet and outlet ports of the muffler may feature an offset, elbow, or turn that would simultaneously allow it to provide means for linear occlusion.
Patent AT-E396236-T1 (AT)
Inventor: SHIROTA KOROMO
IPC: B41J2/01
Filed: 2002-08-21
Granted: 2008-06-15
Abstract: Provided is an ink which comprises an aqueous medium and a coloring material dispersed in the aqueous medium with a dispersant, where the coloring material is contained in an amount of at most 1% by weight with respect to the total weight of the ink, and the ratio (B/P ratio) of the dispersant to the coloring material is larger than 1.
Patent AT-E311282-T1 (AT)
Inventor: VOGEL KLAUS
IPC: B29C49/06
Filed: 2000-03-27
Granted: 2005-12-15
Abstract: A container blowing station has blowing molds comprising two or more segments(35,36) held by supports(48,49). A guide(5) is provided for a mold segment which can move relative to its support. The guide is connected to the segment by a hard core(8) embedded in an elastomer(9) attached to the support.
Patent AT-E342236-T1 (AT)
Inventor: BARAK AYALA
IPC: A01N59/08
Filed: 1992-05-29
Granted: 2006-11-15
Abstract: A process for killing microorganisms and controlling biofouling in high chlorine demand, fresh waters comprises the steps of forming a mixture of two components, one of which is an oxidant selected from Cl2 GAS, NaOCl, Ca(OCl)2, and electrolytically generated chlorine and the other an ammonium salt, and immediatly thereafter adding the mixture to the aqueous system to be treated with the proviso that at least one of the two components is not in solid form.
Patent AT-E391057-T1 (AT)
Inventor: MAEKINEN RAUNO
IPC: B60R25/24
Filed: 2002-06-26
Granted: 2008-04-15
Abstract: A car hands-free unit (HFU 140) with a Low-Power RadioFrequency (LPRF) module 141 (typically a Bluetooth module) configured to receive an identifier 134 from a car key 133. Different drivers are provided with different car keys 133. When receiving the identifier 134 first time, the HFU stores trusted data to pair with a driver's phone. Thereafter, the HFU automatically connects to the driver's phone when the same car key 133 is used. The hands-free unit typically comprises a microphone and a loudspeaker, and can also have a display and/or a camera. In operation the HFU provides automatic link 160 with a compliant LPRF enabled mobile phone without need to touch the mobile phone, allowing its use even when the mobile phone is placed in a boot of a car 101. <IMAGE>
Patent AT-E485258-T1 (AT)
Inventor: POTTER BARRY
IPC: A61K31/19
Filed: 2002-03-07
Granted: 2010-11-15
Abstract: The present invention provides use of a compound in the manufacture of a medicament to inhibit 11beta-HSD activity, wherein the compound is selected from glycyrrhetinic acid derivatives, progesterone and progesterone derivatives.
Patent AT-E334465-T1 (AT)
Inventor: VAN DER VEEN MINNE
IPC: H04N7/08
Filed: 2002-04-19
Granted: 2006-08-15
Abstract: Disclosed is a method of embedding a watermark in an information signal (x(n)), such as an audio signal. The method comprises the steps of segmenting the audio signal into overlapping frames (xs(n)) using a set of analysis windows (ha(n)), calculating watermark segments (ws'(n)) for the overlapping frames, reconstructing a watermark signal (w'(n)) from the watermark segments using a set of reconstruction windows (hr(n)) which are complementary to the analysis windows, and adding the watermark signal to the information signal. The analysis and reconstruction windows may be constructed on the basis of prototype windows to fulfil predetermined complementary conditions. The analysis and reconstruction windows may be adapted to the contents of the information signal.
Patent AT-E353767-T1 (AT)
Inventor: MUERDTER HERBERT
IPC: B41J3/407
Filed: 2002-03-07
Granted: 2007-03-15
Abstract: A problem associated with label printers for liner-free labels is that the self-adhesive coated surface (4) of the label strip to be printed is exposed as it passes through the printer and is guided over a roller (10) that transports the label strip through the printer. Said strip must be released from the roller to be issued at the exit (15) of the printer. According to the invention, instead of the provision of conventional scraper elements downstream of the roller (10), the label strip is embossed, which counteracts the tendency of the label strip to become wound around the roller (10), thus enabling the label strip to be detached from the roller (10) in a reliable manner.
Patent AT-E290562-T1 (AT)
Inventor: LOPEZ LEONARDO C
IPC: B05D7/24
Filed: 2002-04-11
Granted: 2005-03-15
Abstract: The present invention provides network polymers obtained by curing compositions that comprise an ester with at least two terminal epoxy groups. Preferred esters include those represented by the formula (1), wherein each R<SUP>1 </SUP>independently represents a substituted or unsubstituted homoaliphatic or heteroaliphatic group; A represents a substituted or unsubstituted homoalkylene, hetemalkylene, arylene, or heteroarylene segment; and n represents an integer equal to or greater than 2.
Patent AT-E359794-T1 (AT)
Inventor: BURK ROBERT M
IPC: A61K31/5575
Filed: 2002-05-06
Granted: 2007-05-15
Abstract: The present invention provides a method of treating ocular hypertension or glaucoma which comprises administering to an animal having ocular hypertension or glaucoma a therapeutically effective amount of a 3, 7 or 3 and 7 thia or oxa prostanoic acid derivative.
Patent AT-E363182-T1 (AT)
Inventor: COLAS NOBLECOURT CHRISTOPHE
IPC: H04J3/06
Filed: 2002-03-21
Granted: 2007-06-15
Abstract: The application describes a method of referencing content in an application. The method comprises, for a content element, creating a reference to the content element and associating that reference with the content element. This enables the content (for example, text or images) to be dissociated from other features related to content; for example, its presentation on the screen. In this way, control over presentation may be achieved separately from control of the content itself. In an example, a Content Provider 402 provides referenced content to an Operator 404. A Programme Provider 400 sends referenced scenarios to the Operator 404. The Operator 404 resolves the reference and sends data for broadcast by the Broadcaster 406. <IMAGE>
Patent AT-E324727-T1 (AT)
Inventor: SOOMRO AMJAD
IPC: H04B7/26
Filed: 2002-06-28
Granted: 2006-05-15
Abstract: A granted TxOP holder transmits the first frame of a QSTA-to-QSTA communication at a power level sufficient to ensure correct reception by the destination and at least detection by the HC, and then, with exceptions, transmits subsequent frames at a power level merely sufficient to ensure correct reception by the destination, regardless of reception or detection by the HC. Subsequent frames that must be received by the HC, such as those changing the TC queue size or requesting extension of the current TxOP, are transmitted at a power sufficient to ensure reception by the HC as well as the destination, as are the last frame(s). The HC is constrained from reclaiming the channel unconditionally merely because of failure to detect activity, and recovery is limited to the TxOP holder.
Patent AT-E416169-T1 (AT)
Inventor: TSENG WEI-HONG
IPC: A61K31/55
Filed: 2002-05-20
Granted: 2008-12-15
Abstract: The present invention provides an efficient synthetic process for making benazepril and analogues thereof by having an intermediate compound undergo epimerization and kinetic resolution.
Patent AT-E347393-T1 (AT)
Inventor: SNYDER EDWARD J
IPC: A61M25/01
Filed: 2002-07-03
Granted: 2006-12-15
Abstract: A medical device or intravascular device, and methods of use. The devices may be tubular and may have a flexible polymer tip. The body may be nitinol and may have cuts part way through along its length to facilitate bending. The device may have a liner which may extend through the tip or form the tip. The device may have markers readily visible on an X-ray viewer during insertion. The tip may have an anti-collapsing structure and may be shaped before use to perform a medical procedure such as treating an aneurysm. The device may have a strong fiber through it for complete removal. The method may include selecting the device, bending the tip, setting the shape, and inserting the device into the patient's anatomy. The shape of the tip may be set by heating with steam and then removing a mandrel.
Patent AT-E522935-T1 (AT)
Inventor: DINWOODIE THOMAS
IPC: E04D13/18
Filed: 2002-07-10
Granted: 2011-09-15
Abstract: Each PV assembly of an array of PV assemblies comprises a base, a PV module and a support assembly securing the PV module to a position overlying the upper surface of the base. Vents are formed through the base. A pressure equalization path extends from the outer surface of the PV module, past the PV module, to and through at least one of the vents, and to the lower surface of the base to help reduce wind uplift forces on the PV assembly. The PV assemblies may be interengaged, such as by interengaging the bases of adjacent PV assemblies. The base may include a main portion and a cover and the bases of adjacent PV assemblies may be interengaged by securing the covers of adjacent bases together.
Patent AT-E478656-T1 (AT)
Inventor: HANES JUSTIN
IPC: A61K9/107
Filed: 2002-06-21
Granted: 2010-09-15
Abstract: The present application is directed to biodegradable polymers, compositions, including microspheres and nanospheres, formed of such polymers, and methods of using such polymers and compositions. In certain embodiments, the subject polymer compositions include therapeutic agents, optionally providing sustained release of the encapsulated agent after administration to a patient.